MOUSE MONOCLONAL-ANTIBODY (WI-MN-1) AGAINST MALIGNANT-MELANOMA
- 1 January 1983
- journal article
- research article
- Vol. 43 (12), 5868-5872
Abstract
A mouse monoclonal antibody, WI-MN-1, was raised against G-361 melanoma cell line. Reactivity of this antibody was characterized by indirect immunofluorescence against 22 cell lines and normal and neoplastic human tissues. Positive reactions were seen against 3 melanoma cell lines (G-361, HT-144, and MeWo). It also reacted against an epidermoid carcinoma cell line (Hep-2) and amnion cells (WISH). The antibody failed to react against cell lines derived from granulocytic leukemias, lymphocytic leukemias, Burkitt''s lymphoma, carcinoma of the lung, carcinoma of the cervix, carcinoma of the colon, carcinoma of the breast, astrocytoma, and a human monocytoid cell line. Mouse melanoma and mouse fibroblast cell lines were also nonreactive. Similarly, there was no reaction against human peripheral blood, bone marrow, spleen, lymph node, thymus, breast, lung, stomach, heart, brain, kidney, liver, skin, or testis. The antibody was also tested by indirect immunofluorescence against 17 samples of metastatic malignant melanoma which were removed from 13 patients. WI-MN-1 gave positive reaction against 16 of these specimens, and it reacted with the cryostat section in the immunoperoxidase test, delineating neoplastic melanoma from the normal brain tissue. The antibody precipitated MW 105,000 and 38,000 antigens from biosynthetically labeled G-361 cells. WI-MN-1 is a useful addition to the panel of monoclonal antibodies against melanoma-associated antigens.This publication has 20 references indexed in Scilit:
- A Comparative Study of the Peroxidase-antiperoxidase Method and an Avidin-Biotin Complex Method for Studying Polypeptide Hormones with Radioimmunoassay AntibodiesAmerican Journal of Clinical Pathology, 1981
- Characterization of Monoclonal Antibodies to Human Melanoma-Associated Antigens234JNCI Journal of the National Cancer Institute, 1981
- Initial characterization of monoclonal antibodies against human monocytes.Proceedings of the National Academy of Sciences, 1980
- Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.Proceedings of the National Academy of Sciences, 1980
- Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms.Proceedings of the National Academy of Sciences, 1980
- COMMON HUMAN MELANOMA-ASSOCIATED ANTIGEN(S) DETECTED BY MONOCLONAL-ANTIBODIES1980
- HUMAN-LYMPHOCYTE MARKERS DEFINED BY ANTIBODIES DERIVED FROM SOMATIC-CELL HYBRIDS .1. HYBRIDOMA SECRETING ANTIBODY AGAINST A MARKER SPECIFIC FOR HUMAN LYMPHOCYTES-B1980
- SPECIFIC IMMUNOREACTIVITY OF HYBRIDOMA-SECRETED MONOCLONAL ANTI-MELANOMA ANTIBODIES TO CULTURED-CELLS AND FRESHLY DERIVED HUMAN-CELLS1980
- Cell surface antigens of human melanoma identified by monoclonal antibody.Proceedings of the National Academy of Sciences, 1979
- Study of antibodies against human melanoma produced by somatic cell hybrids.Proceedings of the National Academy of Sciences, 1978